Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Bausch & Lomb Incorporated

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1992-10-08

Employees: -

Market Cap: -

Website

Clinical Trials

A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers

Phase 1

Not yet recruiting

Conditions: Ocular Pain

Interventions: Drug: BL1332 ophthalmic solution
Drug: BL1332 ophthalmic vehicle

First Posted Date: 2025-05-18

Last Posted Date: 2025-05-18

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 24

Registration Number: NCT06978244

Locations: 🇺🇸
Site 101, Fair Lawn, New Jersey, United States

A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness

Phase 3

Recruiting

Conditions: Ocular Redness

Interventions: Drug: BTOS-HA
Drug: Lumify®

First Posted Date: 2025-01-31

Last Posted Date: 2025-06-05

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 554

Registration Number: NCT06803654

Locations: 🇺🇸
Site 102, Glendale, California, United States
🇺🇸
Site 103, Newport Beach, California, United States
🇺🇸
Site 105, Garner, North Carolina, United States

and more 2 locations

Revive Toric RWE Study

Not yet recruiting

Conditions: Astigmatism

First Posted Date: 2025-01-21

Last Posted Date: 2025-06-05

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 30

Registration Number: NCT06785194

Locations: 🇺🇸
Site 101, Orange Park, Florida, United States
🇺🇸
Site 102, Orange Park, Florida, United States
🇺🇸
Site 103, Canton, Georgia, United States

Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy

Not Applicable

Not yet recruiting

Conditions: Myopia

Interventions: Device: TENEO 317 Model 2 excimer laser

First Posted Date: 2024-10-01

Last Posted Date: 2025-06-15

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 140

Registration Number: NCT06618547

A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction

Not Applicable

Active, not recruiting

Conditions: Cataract

Interventions: Device: enVista Aspire EA or Aspire Toric ETA IOLs

First Posted Date: 2024-09-19

Last Posted Date: 2025-04-17

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 450

Registration Number: NCT06594185

Locations: 🇺🇸
Site 118, Birmingham, Alabama, United States
🇺🇸
Site 154, Bullhead City, Arizona, United States
🇺🇸
Site 137, Chandler, Arizona, United States

and more 59 locations

A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.

Phase 4

Active, not recruiting

Conditions: Dry Eye

Interventions: Drug: Miebo
Drug: Saline

First Posted Date: 2024-08-22

Last Posted Date: 2024-12-17

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 216

Registration Number: NCT06565650

Locations: 🇺🇸
Site 101, Glendale, California, United States
🇺🇸
Site 112, Murrieta, California, United States
🇺🇸
Site 102, Newport Beach, California, United States

and more 9 locations

Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens

Not Applicable

Terminated

Conditions: Cataract

Interventions: Device: MX60E
Device: An IOL with a slightly extended depth of focus
Device: enVista® Aspire™

First Posted Date: 2024-06-28

Last Posted Date: 2024-12-27

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 27

Registration Number: NCT06479148

Locations: 🇭🇳
Site 101 Centro Oftalmológico Robles, Santa Rosa De Copán, Copán, Honduras

A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy

Phase 4

Completed

Conditions: Dry Eye

Interventions: Drug: Miebo

First Posted Date: 2024-04-04

Last Posted Date: 2025-04-15

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 97

Registration Number: NCT06346340

Locations: 🇺🇸
Site 109, Sacramento, California, United States
🇺🇸
Site 111, Grand Junction, Colorado, United States
🇺🇸
Site 108, Alexandria, Minnesota, United States

and more 9 locations

A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction

Completed

Conditions: Cataract

Interventions: Device: enVista Aspire EA IOLs

First Posted Date: 2024-03-27

Last Posted Date: 2025-05-02

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 82

Registration Number: NCT06333028

Locations: 🇺🇸
SITE 104, Dover, New Jersey, United States
🇺🇸
Site 105, Woodland Park, New Jersey, United States
🇺🇸
Site 103, Garden City, New York, United States

and more 4 locations

Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction

Not Applicable

Recruiting

Conditions: Cataract

Interventions: Device: enVista EY Beyond IOL
Device: enVista MX60E monofocal IOL

First Posted Date: 2024-03-27

Last Posted Date: 2025-07-02

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 224

Registration Number: NCT06333015

Locations: 🇺🇸
Site 115, Sugar Land, Texas, United States
🇺🇸
Site 108, Northridge, California, United States
🇺🇸
Site 107, Bloomington, Minnesota, United States

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy